Drugs / Depiquick Birch
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01902992 | Mar → Jul 2012 | allergic disease | Novartis | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Depiquick Birch | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01902992 ↗ |
| Known as | DPG103 | “Depiquick Birch (DPG103)” NCT01902992 ↗ |
| Modality | Other / unclassified | “Depigmented Glutaraldehyde Polymerized Birch Pollen Allergenic Extract (Depiquick® Birch)” NCT01902992 ↗ |
| Route | Subcutaneous | “subcutaneous injections” NCT01902992 ↗ |